» Articles » PMID: 33664584

Dysiarenone from Marine Sponge Attenuates ROS and Inflammation Via Inhibition of 5-LOX/NF-κB/MAPKs and Upregulation of Nrf-2/OH-1 in RAW 264.7 Macrophages

Overview
Journal J Inflamm Res
Publisher Dove Medical Press
Date 2021 Mar 5
PMID 33664584
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Marine natural products harbor a variety of pharmacological activities, and the sea species have been becoming a main source of new drug candidate. In pursuit of safer and more effective anti-inflammation drug, the anti-inflammatory activities, anti-oxygenation effects and underlying molecular mechanisms of compound dysiarenone from were investigated via LPS-induced RAW 264.7 cell model.

Methods: Firstly, RAW 264.7 cells have been stimulated with LPS and treated with dysiarenone, and the cell viability of the LPS-treated RAW 264.7 cells was examined. One-step method, DCFH-DA fluorescence probe method was used to detect reactive oxygen species (ROS). The modulation of dysiarenone on anti-inflammation was detected by enzyme-linked immunosorbent assay by measuring the release of inflammatory cytokines (TNF-α and IL-6), and inflammatory mediators (LTB4). Further, the underlying anti-inflammatory mechanism of dysiarenone was explored by determining the expression of inducible 5-LOX, MAPKs, p-Akt, and p-NF-κB p65. Oxidative stress is tightly connected with inflammation, which was also evaluated through nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (OH-1) signaling pathway.

Results: Our study unraveled that dysiarenone between 2 and 8 µM reduces the inflammation responses via suppressing the production of inflammatory cytokines (TNF-α and IL-6) and inflammatory mediators (LTB). Dysiarenone down-regulated the protein levels of inducible 5-LOX via the inhibition of phosphorylation of MAPKs (including p38, ERK), Akt and NF-κB p65. Additionally, dysiarenone decreases ROS accumulation by upregulating HO-1 expression via nuclear translocation of Nrf2.

Conclusion: In conclusion, we demonstrated that dysiarenone possesses anti-inflammation and anti-oxidation activity via inhibiting 5-LOX/NF-κB/MAPK and Nrf2/HO-1 signaling pathway. Dysiarenone might be a promising lead compound for inflammatory diseases.

Citing Articles

Pathological roles of mitochondrial dysfunction in endothelial cells during the cerebral no-reflow phenomenon: A review.

Luo X, Zhang S, Wang L, Li J Medicine (Baltimore). 2024; 103(51):e40951.

PMID: 39705421 PMC: 11666140. DOI: 10.1097/MD.0000000000040951.


Marine Pharmacology in 2019-2021: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous....

Mayer A, Mayer V, Swanson-Mungerson M, Pierce M, Rodriguez A, Nakamura F Mar Drugs. 2024; 22(7).

PMID: 39057418 PMC: 11278370. DOI: 10.3390/md22070309.


Overexpression of Plakophilin2 Mitigates Capillary Leak Syndrome in Severe Acute Pancreatitis by Activating the p38/MAPK Signaling Pathway.

Liu H, Xu X, Li J, Liu Z, Xiong Y, Yue M J Inflamm Res. 2024; 17:4129-4149.

PMID: 38952564 PMC: 11215460. DOI: 10.2147/JIR.S459449.

References
1.
Deshmukh P, Unni S, Krishnappa G, Padmanabhan B . The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases. Biophys Rev. 2017; 9(1):41-56. PMC: 5425799. DOI: 10.1007/s12551-016-0244-4. View

2.
Jiao W, Shi G, Xu T, Chen G, Gu B, Wang Z . Dysiherbols A-C and Dysideanone E, Cytotoxic and NF-κB Inhibitory Tetracyclic Meroterpenes from a Dysidea sp. Marine Sponge. J Nat Prod. 2016; 79(2):406-11. DOI: 10.1021/acs.jnatprod.5b01079. View

3.
Heppner F, Ransohoff R, Becher B . Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015; 16(6):358-72. DOI: 10.1038/nrn3880. View

4.
Jiao W, Cheng B, Shi G, Chen G, Gu B, Zhou Y . Dysivillosins A-D, Unusual Anti-allergic Meroterpenoids from the Marine Sponge Dysidea villosa. Sci Rep. 2017; 7(1):8947. PMC: 5567184. DOI: 10.1038/s41598-017-04021-z. View

5.
Zhang X, Ding M, Zhu P, Huang H, Zhuang Q, Shen J . New Insights into the Nrf-2/HO-1 Signaling Axis and Its Application in Pediatric Respiratory Diseases. Oxid Med Cell Longev. 2019; 2019:3214196. PMC: 6885770. DOI: 10.1155/2019/3214196. View